AI-generated summary
The authors report a double-blind, sham-controlled randomized trial of fractional carbon dioxide laser in 85 postmenopausal women with vaginal symptoms. At 12 months, the laser group did not differ significantly from the sham group in symptom severity, quality of life, or vaginal health scores. The study was conducted at a single hospital in Australia.
- Participants
- 85
- Who or what was studied
- Postmenopausal women with vaginal symptoms severe enough to seek medical treatment, mean age 57 years, recruited at a single tertiary referral hospital in Sydney, Australia.
- Limits stated in the abstract
- The abstract reports a single-center trial with 85 randomized participants and a sham comparator, and it does not state a wavelength for the carbon dioxide laser.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jamanetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham, Visual analogue scale, Minimal clinically important difference, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.